ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "mental health"

  • Abstract Number: 107 • 2020 Pediatric Rheumatology Symposium

    Defining the Prevalence of Depression and Anxiety Symptoms in Adolescents with Juvenile Idiopathic Arthritis

    Lydia Li1, Mehveen Merchant 2, Shelina Gordon 3, David Lovas 4, Joanne Gillespie 4, Adam Huber 5, Bianca Lang 6, Suzanne Ramsey 4 and Elizabeth Stringer 4, 1Dalhousie University, Halifax, Canada, 2Calgary, Canada, 3IWK Health Centre, Halifax, 4IWK Health Centre, Halifax, Canada, 5IWK Health Centre & Dalhousie University, Halifax, Nova Scotia, Canada, 6Dalhousie University - Halifax, Halifax, Canada

    Background/Purpose: We aimed to evaluate the prevalence of depressive and/or anxiety symptoms in adolescents with juvenile idiopathic arthritis (JIA) and explore the association with demographic…
  • Abstract Number: 125 • 2020 Pediatric Rheumatology Symposium

    Feasibility and Pilot Study of Mental Health Screening in Juvenile Myositis

    Kaveh Ardalan1, Alison Manning 1, Brian Feldman 2, Gary Maslow 1 and Andrea Knight 3, 1Duke University Medical Center, Durham, 2The Hospital for Sick Children, Toronto, Canada, 3SickKids Research Institute, Toronto, Canada

    Background/Purpose: Juvenile myositis (JM) negatively affects health-related quality of life due to chronic weakness, skin/muscle damage, multiorgan dysfunction, and side effects of immunosuppression. While JM’s…
  • Abstract Number: 170 • 2020 Pediatric Rheumatology Symposium

    Clinical Team Perspectives on the Transition from Pediatric to Adult Care for Patients with Childhood-Onset SLE

    Nicole Bitencourt1, Justin Kramer 2, Bonnie Bermas 3, Elizabeth Solow 2, Tracey Wright 2 and Una Makris 2, 1UT Southwestern Medical Center, Dallas, Texas, 2UT Southwestern Medical Center, Dallas, 3UTSouthwestern Medical Center, Dallas

    Background/Purpose: The transition from pediatric to adult care for youth with chronic disease is known to be a vulnerable period, with adverse outcomes described for…
  • Abstract Number: 032 • 2020 Pediatric Rheumatology Symposium

    The Impact of Psychiatric Diagnosis and Treatment on Medication Adherence in Youth with Systemic Lupus Erythematosus

    Joyce Chang1, Alaina Davis 2, Marisa Klein-Gitelman 3, Zuleyha Cidav 4, David Mandell 5 and Andrea Knight 6, 1Children's Hospital of Philadelphia, Philadelphia, 2Monroe Carell Jr. Children’s Hospital at Vanderbilt, Nashville, Tennessee, 3Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, 4University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, 5Perelman School of Medicine at the University of Pennsylvania, Philadelphia, 6SickKids Research Institute, Toronto, Canada

    Background/Purpose: Youth with systemic lupus erythematosus (SLE) experience significant health care burden and high rates of psychiatric disorders. Optimizing medication adherence is critical for preventing…
  • Abstract Number: 040 • 2020 Pediatric Rheumatology Symposium

    Patient-Proxy Agreement on Mental Health and Neuropsychological Symptoms Among Youth with Juvenile Fibromyalgia Syndrome

    Sabrina Gmuca1, Maitry Sonagra 2, Rui Xiao 3, Nina Thomas 4, Kimberly S. Miller 4, Jami F. Young 4, Pamela Weiss 4, David D. Sherry 4 and Jeffrey S. Gerber 4, 1Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 2Children's Hospital of Philadelphia, Cherry Hill, 3University of Pennsylvania, Philadelphia, 4Children's Hospital of Philadelphia, Philadelphia

    Background/Purpose: Adolescents with juvenile fibromyalgia syndrome (JFMS) present with a myriad of mental health and neuropsychological symptoms, including dyscognition (“brain fog”); however, patient-proxy agreement on…
  • Abstract Number: 090 • 2020 Pediatric Rheumatology Symposium

    Using a Patient-Engaged Approach to Identify Cross-Cutting Disease Factors Impacting Mental Health in Youth with Rheumatologic Disease

    Ashley Danguecan1, Oluwatunmise Fawole 2, Michelle Reed 3, Julia Harris 4, Aimee Hersh 5, Martha Rodriquez 6, Karen Onel 7, Erica Lawson 8, Tamar Rubinstein 9, Kaveh Ardalan 10, Esi Morgan 11, Anne Paul 12, Judy Barlin 13, R. Paola Daly 14, Mitali Dave 15, Shannon Malloy 16, Shari Hume 17, Suzanne Schrandt 18, Laura Marrow 19, Angela Chapson 20, Donna Napoli 3, Michael Napoli 3, Miranda Moyer 3, Vincent Del Gaizo 21, Emily von Scheven 22 and Andrea Knight 23, 1Hospital for Sick Children, Toronto, Canada, 2New York University School of Medicine, New York, 3The Children's Hospital of Philadelphia, Philadelphia, 4Children's Mercy Kansas City, Overland Park, 5University of Utah Primary Children's Hospital, Salt Lake City, 6Riley Hospital For Children At Indiana University, Carmel, 7Hospital for Special Surgery, New York, 8UCSF, San Francisco, 9Albert Einstein College of Medicine, White Plains, 10Duke University Medical Center, Durham, 11Cincinnati Children's Hospital, Cincinnati, 12Cincinnati Children's Hospital Medical Centre, Cincinnati, 13Lupus Foundation of America, Miami, 14Lupus Foundation of America, Washington, 15Short Hills, 16Cure JM Foundation, Leesburg, 17Encinitas, 18Arthritis Foundation, Atlanta, 19Arthritis Foundation, Saint Paul, 20Children's Hospital of Philadelphia, Philadelphia, 21Childhood Arthritis & Rheumatology Research Alliance (CARRA), Whitehouse Station, 22San Francisco, 23SickKids Research Institute, Toronto, Canada

    Background/Purpose: Mental health problems are common and often untreated in youth with rheumatologic disease, yet their relationship with disease features is poorly understood. We engaged…
  • Abstract Number: 914 • 2018 ACR/ARHP Annual Meeting

    Increased Adverse Childhood Experiences in Children with Arthritis: An Analysis of the National Survey of Children’s Health

    Tamar Rubinstein1, Danielle R. Bullock2, Kaveh Ardalan3, Wenzhu B. Mowrey4, Nicole Brown5 and Ruth E K Stein6, 1Pediatric Rheumatology, Albert Einstein College of Medicine, Children's Hospital at Montefiore, Bronx, NY, 2Pediatrics, University of Minnesota, Minneapolis, MN, 3Division of Rheumatology, Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL, 4Albert Einstein College of Medicine, Bronx, NY, 5Albert Einstein College of Medicine/ Children's Hospital at Montefiore, Bronx, NY, 6Pediatrics, Albert Einstein College of Medicine, Bronx, NY

    Background/Purpose: Adverse Childhood Experiences (ACEs) are associated with increased risk of chronic disease and poorer health in children and adults. Emerging data suggest an association…
  • Abstract Number: 1432 • 2018 ACR/ARHP Annual Meeting

    Engaging Patients and Parents to Improve Mental Health for Youth with Rheumatologic Disease

    Oluwatunmise Fawole1, Michelle Vickery2, Lauren Faust3, Tamar Rubinstein4, Julia Harris5, Aimee O. Hersh6, Karen Onel7, Erica Lawson8, Emily von Scheven9, Kaveh Ardalan10, Esi Morgan11, Anne Paul12, Judith Barlin13, R. Paola Daly13, Mitali Dave14, Shannon Malloy15, Shari Hume15, Suzanne Schrandt16, Laura C. Marrow17, Angela Chapson3, Donna Napoli3, Michael Napoli3, Miranda Moyer3, Rachel Adamski3, Vincent Del Gaizo18, Martha Rodriguez19 and Andrea M. Knight20, 1The Children's Hospital of Philadelphia, Philadelphia, PA, 2Hershey Medical Center, Hershey, PA, 3Children's Hospital of Philadelphia, Philadelphia, PA, 4Pediatric Rheumatology, Albert Einstein College of Medicine, Children's Hospital at Montefiore, Bronx, NY, 5Children's Mercy - Kansas City, Kansas City, MO, 6Pediatrics/Rheumatology, University of Utah, Salt Lake City, UT, 7Division of Pediatric Rheumatology, University of Chicago, Chicago, IL, 8Pediatrics/Rheumatology, University of California, San Francisco, San Francisco, CA, 9Pediatric Rheumatology, University of California San Francisco, San Francisco, CA, 10Division of Rheumatology; Department of Pediatrics, Ann & Robert H. Lurie Children’s Hospital of Chicago/Northwestern University Feinberg School of Medicine, Chicago, IL, 11University of Cincinnati, Cincinnati, OH, 12Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 13Lupus Foundation of America, Washington, DC, 14Cure JM Foundation, Encintas, CA, 15Cure JM Foundation, Encinitas, CA, 16Arthritis Foundation, Saint Paul, MN, 17Arthritis Foundation, Atlanta, GA, 18Parent Partner, Whitehouse Station, NJ, 19Riley Children’s Hospital at Indiana, Indianapolis, IN, 20Center for Pediatric Clinical Effectiveness & PolicyLab, Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: Mental health conditions are common in youth with rheumatologic disease, yet intervention strategies are understudied. We used a patient-engaged approach to investigate the mental…
  • Abstract Number: 1651 • 2018 ACR/ARHP Annual Meeting

    Epidemiology of Depression and Anxiety in Patients with Psoriatic Arthritis: A Systematic Review and Meta-Analysis

    Enav Z. Zusman1,2,3, Alyssa Howren1,2,3, Jan Dutz4 and Mary A. De Vera1,2,3, 1Collaboration for Outcomes Research and Evaluation (CORE), Vancouver, BC, Canada, 2Arthritis Research Canada, Richmond, BC, Canada, 3Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, 4Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: Shared inflammatory processes underscore a substantial burden and risk of psychiatric complications – namely depression and anxiety – in patients with psoriatic arthritis (PsA),…
  • Abstract Number: 1847 • 2018 ACR/ARHP Annual Meeting

    Screening Youth with Lupus for Depression and Anxiety in Pediatric Rheumatology Clinics

    Tamar Rubinstein1, Marija Dionizovik-Dimanovski2, Chelsey Smith3, Raphael Kraus4, Jordan T. Jones5, Julia Harris6, Martha Rodriguez7, Lauren Faust8, Beth Rutstein8, Rebecca Puplava9, Melissa Tesher9, Alaina M. Davis10, Karen Onel11, Sangeeta Sule12, Emily von Scheven13 and Andrea M. Knight14, 1Pediatric Rheumatology, Albert Einstein College of Medicine, Children's Hospital at Montefiore, Bronx, NY, 2Pediatric Rheumatology, Children's Hospital at Montefiore, Bronx, NY, 3Children's Mercy Kansas City, Kansas City, MO, 4Children's Hospital at Montefiore, Bronx, NY, 5University of Kansas, Kansas City, KS, 6Children's Mercy - Kansas City, Kansas City, MO, 7Riley Children’s Hospital at Indiana, Indianapolis, IN, 8Children's Hospital of Philadelphia, Philadelphia, PA, 9University of Chicago Medicine, Chicago, IL, 10Division of Pediatric Rheumatology, Monroe Carell Junior Children's Hospital at Vanderbilt, Nashville, TN, 11Hospital for Special Surgery, New York, NY, 12Pediatrics, Johns Hopkins University, Baltimore, MD, 13Pediatric Rheumatology, University of California San Francisco, San Francisco, CA, 14Center for Pediatric Clinical Effectiveness & PolicyLab, Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: Despite high rates of depression and anxiety in pediatric lupus, standardized mental health screening is not routinely practiced by pediatric rheumatologists. Our objectives were…
  • Abstract Number: 630 • 2017 ACR/ARHP Annual Meeting

    Effects of Intravenous Golimumab, an Anti-Tnfα Monoclonal Antibody, on Mental and Physical Functioning and Health-Related Quality of Life in Active Psoriatic Arthritis: 24-Week Results of a Phase 3 Trial

    M. Elaine Husni1, Arthur Kavanaugh2, Eric K. H. Chan3, Nan Li4, Steven Peterson4, Elizabeth C. Hsia5, Lilianne Kim4, Kim Hung Lo4 and Diane D. Harrison4, 1Rheumatology, Cleveland Clinic, Cleveland, OH, 2Medicine, University of California, San Diego, La Jolla, CA, 3Janssen Global Services, LLC, Raritan, NJ, 4Janssen Research & Development, LLC, Spring House, PA, 5Janssen Research & Development, LLC/University of Pennsylvania, Spring House/Philadelphia, PA

    Background/Purpose: To evaluate physical and mental health functioning, health state, and health-related quality of life (HRQoL) in patients with active psoriatic arthritis (PsA) treated with…
  • Abstract Number: 998 • 2017 ACR/ARHP Annual Meeting

    Mental Health in Patients with Axial Spondyloarthritis: Increasing Our Understanding of the Disease. Results from the Spanish Atlas

    Marco Garrido-Cumbrera1, Victoria Navarro-Compán2, David Galvez-Ruiz1, Carlos Jesus Delgado Dominguez1, Pilar Font-Ugalde3, Olta Brace1, Pedro Zarco4, Jorge Chacon-Garcia1 and Pedro Plazuelo-Ramos5, 1Universidad de Sevilla, Seville, Spain, 2Rheumatology, Hospital Universitario La Paz, Madrid, Spain, 3Rheumatology service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 4H Fundación Alcorcón, Alcorcón, Spain, 5CEADE, Madrid, Spain

    Background/Purpose: This study’s aim was to assess the association between sociodemographic characteristics, disease progression, and mental health comorbidity with risk of mental disorders (RMD).Methods: In…
  • Abstract Number: 129 • 2015 ACR/ARHP Annual Meeting

    Rheumatologists’ Approaches to Diagnosis and Treatment of Depression

    Erica Heiman, Barton Wise and Richard L. Kravitz, Department of Internal Medicine, UC Davis Medical Center, Sacramento, CA

    Background/Purpose: Depression in patients with rheumatic disorders contributes to morbidity, mortality, and health care utilization. We set out to examine rheumatologists’ approaches to and perceptions…
  • Abstract Number: 395 • 2015 ACR/ARHP Annual Meeting

    Depression Risk Among Adults with Childhood- and Adult-Onset Systemic Lupus Erythematosus: 11 Years of Follow-up

    Erica F. Lawson1, Andrea Knight2, Laura Trupin3, Patricia P. Katz3 and Edward H. Yelin4, 1Pediatrics/Rheumatology, UC San Francisco, San Francisco, CA, 2Pediatrics/Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, 3Medicine/Rheumatology, University of California San Francisco, San Francisco, CA, 4Medicine/Rheumatology, UC San Francisco, San Francisco, CA

    Background/Purpose: Neuropsychiatric syndromes are prevalent in childhood-onset systemic lupus erythematosus (cSLE), but the long-term risk of depression in adults with cSLE is unknown. We compared…
  • Abstract Number: 1299 • 2014 ACR/ARHP Annual Meeting

    A Cross-Sectional Study of Mental Health Symptoms and Mental Health Care in Pediatric SLE/MCTD Patients and Their Peers

    Andrea Knight1,2, Michelle Vickery1, Pamela Weiss1,2,3, Knashawn Morales3 and Ron Keren3,4, 1Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA, 2Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, 3Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, 4Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: Mental health problems are prevalent in pediatric systemic lupus erythematosus (SLE). We aimed to compare the rates of mental health problems and mental health…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology